Evoclin Connetics Corporation - Treatment for Acne
Evoclin (formerly referred to as Actiza) is 1% clindamycin delivered in Connetics’ proprietary VersaFoam vehicle. Evoclin is indicated for the topical treatment acne vulgaris.Posted: October 2004
Related articles
Evoclin (clindamycin phosphate) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
